- Home
- WRAP vs MNOV Comparison
WRAP vs MNOV Comparison
Compare WRAP & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- MNOV
- Stock Information
- Founded
- WRAP 2016
- MNOV 2000
- Country
- WRAP United States
- MNOV United States
- Employees
- WRAP N/A
- MNOV N/A
- Industry
- WRAP Ordnance And Accessories
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- MNOV Health Care
- Exchange
- WRAP Nasdaq
- MNOV Nasdaq
- Market Cap
- WRAP 73.3M
- MNOV 68.2M
- IPO Year
- WRAP N/A
- MNOV 2005
- Fundamental
- Price
- WRAP $1.54
- MNOV $1.27
- Analyst Decision
- WRAP
- MNOV Strong Buy
- Analyst Count
- WRAP 0
- MNOV 2
- Target Price
- WRAP N/A
- MNOV $7.00
- AVG Volume (30 Days)
- WRAP 190.0K
- MNOV 17.4K
- Earning Date
- WRAP 05-15-2025
- MNOV 08-07-2025
- Dividend Yield
- WRAP N/A
- MNOV N/A
- EPS Growth
- WRAP N/A
- MNOV N/A
- EPS
- WRAP N/A
- MNOV N/A
- Revenue
- WRAP $3,796,000.00
- MNOV N/A
- Revenue This Year
- WRAP N/A
- MNOV N/A
- Revenue Next Year
- WRAP N/A
- MNOV N/A
- P/E Ratio
- WRAP N/A
- MNOV N/A
- Revenue Growth
- WRAP N/A
- MNOV N/A
- 52 Week Low
- WRAP $1.30
- MNOV $1.12
- 52 Week High
- WRAP $2.58
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- WRAP 48.85
- MNOV 40.89
- Support Level
- WRAP $1.48
- MNOV $1.32
- Resistance Level
- WRAP $1.60
- MNOV $1.38
- Average True Range (ATR)
- WRAP 0.08
- MNOV 0.05
- MACD
- WRAP -0.01
- MNOV -0.00
- Stochastic Oscillator
- WRAP 29.35
- MNOV 15.38
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.